|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4709 | (2006.01) |
| A61K 31/4709 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 33/243 | (2019.01) | ||
| A61K 33/243 | (2019.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Number of the document | 3744325 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19740851.1 |
| Date of filing the European patent application | 2019-01-16 | |
| (97) | Date of publication of the European application | 2020-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2019/071846 |
| Date | 2019-01-16 |
| (87) | Number | WO 2019/141170 |
| Date | 2019-07-25 |
| (30) | Number | Date | Country code |
| 201810058487 | 2018-01-22 | CN |
| (72) |
HUA, Yingqi , CN
WANG, Gangyang , CN
CAI, Zhengdong , CN
WANG, Zhuoying , CN
ZHANG, Tao , CN
WANG, Hongsheng , CN
SUN, Mengxiong , CN
WANG, Xunqiang , CN
ZHAN, Xiaole , CN
YANG, Zhaoqiang , CN
TU, Lifan , CN
LI, Pu , CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ,
No. 369 Yuzhou South Road, Lianyungang, Jiangsu 222062,
CN
|
| (54) | APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA |
| APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA |